IGM Biosciences Inc Cash Flow Reinvestment Rate
Latest as of June 2022:
1.67x
IGM Biosciences Inc cash flow reinvestment rate. IGM Biosciences Inc (IGMS) has a Cash Flow Reinvestment Rate of 1.67x as of June 2022, reinvesting $185.78 Million (capex $1.82 Million plus investments $-183.96 Million) from operating cash flow of $111.29 Million. Explore IGM Biosciences Inc (IGMS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
1.67x
(Capex + Investments) / Operating CF
Total Reinvested
$185.78 Million
Capex + Investments
Operating Cash Flow
$111.29 Million
USD
Capital Expenditures
$1.82 Million
USD
IGM Biosciences Inc Cash Flow Reinvestment Rate by Year (None–None)
IGM Biosciences Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for IGM Biosciences Inc. For the full cash flow conversion analysis, see how efficiently does IGM Biosciences Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow